Cannabis Research: Cannabidiol’s Impact on Glucose Tolerance & Gut Microbiome in Obese Adults
Comments Off on Cannabis Research: Cannabidiol’s Impact on Glucose Tolerance & Gut Microbiome in Obese Adults
May 8, 2026
Clinical Takeaway In this pilot study, short-term low-dose CBD supplementation did not significantly improve glucose tolerance, alter gut microbiome composition, or reduce inflammation in sedentary adults with overweight or obesity. While animal studies…
GLP-1 Receptor Agonist Coverage: Sleep Apnea Legal Battle
Comments Off on GLP-1 Receptor Agonist Coverage: Sleep Apnea Legal Battle
April 11, 2026
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic GLP-1 Insurance DenialSleep Apnea CoverageElevance Health LawsuitClass Action BenefitsGLP-1…